# Joel E. Gallant

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joel-e-gallant/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,668 |
| Field | HIV/AIDS drug development and treatment |
| h-index | 67 |
| i10-index | 151 |
| Last Known Institution | Gilead Sciences (United States) |
| OpenAlex ID | https://openalex.org/A5048477426 |
| ORCID iD | https://orcid.org/0000-0002-7144-1642 |
| Works | 286 |

## Researcher papers

- [Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 <sup>+</sup> T Cells](https://scholariq.org/papers/residual-human-immunodeficiency-virus-type-1-viremia-in-some-patients-on/)

## Researcher topics

- [HIV/AIDS drug development and treatment](https://scholariq.org/topics/hiv-aids-drug-development-and-treatment/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)
- [HIV Research and Treatment](https://scholariq.org/topics/hiv-research-and-treatment/)
- [HIV-related health complications and treatments](https://scholariq.org/topics/hiv-related-health-complications-and-treatments/)
- [Pneumocystis jirovecii pneumonia detection and treatment](https://scholariq.org/topics/pneumocystis-jirovecii-pneumonia-detection-and-treatment/)

## Researcher university

- [Gilead Sciences (United States)](https://scholariq.org/institutions/gilead-sciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.